Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 12Not yet recruiting 3Active not recruiting 3Completed 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Sarcoma 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 80Neoplasms 61Colorectal Neoplasms 42Prostatic Neoplasms 41Carcinoma, Non-Small-Cell Lung 35Lung Neoplasms 31Multiple Myeloma 23Leukemia, Myeloid, Acute 23Head and Neck Neoplasms 22Pancreatic Neoplasms 15Melanoma 15Squamous Cell Carcinoma of Head and Neck 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Ovarian Neoplasms 14Neoplasm Metastasis 14Carcinoma, Hepatocellular 14Recurrence 13Lymphoma, Non-Hodgkin 13Stomach Neoplasms 12Colonic Neoplasms 11Uterine Cervical Neoplasms 10Rectal Neoplasms 10Lymphoma 10Esophageal Neoplasms 10Carcinoma, Renal Cell 10Brain Neoplasms 10Motor Activity 9Kidney Neoplasms 9Myelodysplastic Syndromes 8Lymphoma, Large B-Cell, Diffuse 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Carcinoma, Ovarian Epithelial × 30 days × Clear all
NCT00086567 2026-06-01

Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

National Institutes of Health Clinical Center (CC)

Completed
119 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms

NCT04902872 2026-05-12

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Cybrexa Therapeutics

Phase 1/2 Completed
69 enrolled
BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Ovarian Epithelial, Appendiceal Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Esophageal Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡